Axa S.A. Concert Pharmaceuticals, Inc. Transaction History

Axa S.A.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$3.17 - $4.15 $71,870 - $94,088	-22,672 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$3.77 - $5.24 $147,407 - $204,884	-39,100 Reduced 63.3%	22,672 $96,000
Q3 2020 Nov 13, 2020	BUY	$8.67 - $10.82 $132,798 - $165,729	15,317 Added 32.97%	61,772 $607,000
Q2 2020 Aug 14, 2020	SELL	$7.8 - $11.52 $215,498 - $318,274	-27,628 Reduced 37.29%	46,455 $462,000
Q3 2019 Nov 14, 2019	SELL	$5.88 - $12.35 $184,632 - $387,790	-31,400 Reduced 29.77%	74,083 $436,000
Q2 2019 Aug 13, 2019	BUY	$9.44 - $13.12 $732,383 - $1.02 Million	77,583 Added 278.08%	105,483 $1.27 Million
Q1 2019 May 14, 2019	BUY	$12.07 - $17.54 $336,753 - $489,366	27,900 New	27,900 $337,000
Q4 2018 Feb 13, 2019	SELL	$11.25 - $16.17 $194,625 - $279,741	-17,300 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$16.83 - $21.66 $149,786 - $192,774	-8,900 Reduced 33.97%	17,300 $291,000
Q1 2018 May 14, 2018	BUY	$19.24 - $28.03 $504,087 - $734,386	26,200 New	26,200 $600,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.